Complementary Role of Echocardiography and Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current Cardiology Reports

• Publication date

  2017-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11886-017-0897-zPMID 28752280
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of Maximal Wall Thickness in Hypertrophic Cardiomyopathy Differs Between Magnetic Resonance Imaging and Transthoracic Echocardiography.

  2017cited by this paper
• Left Atrial Size and Function in Hypertrophic Cardiomyopathy Patients and Risk of New-Onset Atrial Fibrillation

  2017cited by this paper
• Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and Management.

  2017cited by this paper
• Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

  2016cited by this paper
• Prognostic Value of LGE-CMR in HCM: A Meta-Analysis.

  2016cited by this paper
• Contemporary Natural History and Management of Nonobstructive Hypertrophic Cardiomyopathy.

  2016cited by this paper
• Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography

  2016cited by this paper
• Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.

  2015cited by this paper
• Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association.

  2015cited by this paper
• Left atrial remodeling in hypertrophic cardiomyopathy and susceptibility markers for atrial fibrillation identified by cardiovascular magnetic resonance.

  2014cited by this paper
• Three-dimensional speckle tracking echocardiography for the preclinical diagnosis of hypertrophic cardiomyopathy

  2014cited by this paper
• Investigation of Global and Regional Myocardial Mechanics With 3-Dimensional Speckle Tracking Echocardiography and Relations to Hypertrophy and Fibrosis in Hypertrophic Cardiomyopathy

  2014cited by this paper
• Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy

  2014cited by this paper
• Global longitudinal strain and left atrial volume index improve prediction of appropriate implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy patients

  2014cited by this paper
• 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).

  2014cited by this paper
• Significance of left ventricular apical-basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.

  2014cited by this paper
• A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD).

  2014cited by this paper
• Atrial Fibrillation in Hypertrophic Cardiomyopathy: Prevalence, Clinical Correlations, and Mortality in a Large High‐Risk Population

  2014cited by this paper
• How to image cardiac amyloidosis.

  2014cited by this paper
• Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy.

  2013cited by this paper
• Clinical characteristics and natural history of hypertrophic cardiomyopathy with midventricular obstruction.

  2013cited by this paper
• Noninvasive assessment of myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy

  2013cited by this paper
• Relationship of phasic left atrial volume and emptying function to left ventricular filling pressure: a cardiovascular magnetic resonance study

  2013cited by this paper
• Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR.

  2013cited by this paper
• Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement

  2013cited by this paper
• Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.

  2012cited by this paper
• Clinical Utility of Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy

  2012cited by this paper
• Multiple myocardial crypts on modified long-axis view are a specific finding in pre-hypertrophic HCM mutation carriers.

  2012cited by this paper
• Left atrial minimum volume and reservoir function as correlates of left ventricular diastolic function: impact of left ventricular systolic function

  2012cited by this paper
• CMR with late gadolinium enhancement in genotype positive-phenotype negative hypertrophic cardiomyopathy.

  2012cited by this paper
• Prognostic importance of late gadolinium enhancement cardiovascular magnetic resonance in cardiomyopathy

  2011cited by this paper
• Prolonged left ventricular twist in cardiomyopathies: a potential link between systolic and diastolic dysfunction.

  2011cited by this paper
• Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy.

  2011cited by this paper
• American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomograph

  2011cited by this paper
• A new method for quantification of left ventricular systolic function using a corrected ejection fraction.

  2011cited by this paper
• 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2011cited by this paper
• Comparison of long and short axis quantification of left ventricular volume parameters by cardiovascular magnetic resonance, with ex-vivo validation

  2011cited by this paper
• Prevalence and Clinical Profile of Myocardial Crypts in Hypertrophic Cardiomyopathy

  2011cited by this paper
• Right ventricular hypertrophy and scarring in mutation positive hypertrophic cardiomyopathy.

  2010cited by this paper
• Reference left atrial dimensions and volumes by steady state free precession cardiovascular magnetic resonance

  2010cited by this paper
• Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy.

  2010cited by this paper
• Myocardial Fibrosis Attenuates the Effect of Cibenzoline on Left Ventricular Diastolic Function in Patients With Hypertrophic Cardiomyopathy

  2010cited by this paper
• Diastolic myocardial mechanics in hypertrophic cardiomyopathy.

  2010cited by this paper
• In Vivo Measurement of Mitral Leaflet Surface Area and Subvalvular Geometry in Patients With Asymmetrical Septal Hypertrophy: Insights Into the Mechanism of Outflow Tract Obstruction

  2010cited by this paper
• Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy

  2010cited by this paper
• Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy

  2010cited by this paper
• Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.

  2010cited by this paper
• Characteristics and surgical outcomes of symptomatic patients with hypertrophic cardiomyopathy with abnormal papillary muscle morphology undergoing papillary muscle reorientation.

  2010cited by this paper
• Outcome of mildly symptomatic or asymptomatic obstructive hypertrophic cardiomyopathy: a long-term follow-up study.

  2009cited by this paper
• Utility of cardiovascular magnetic resonance in the diagnosis of Anderson-Fabry disease.

  2009cited by this paper
• Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.

  2009cited by this paper
• Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.

  2009cited by this paper
• Papillary muscle realignment for symptomatic left ventricular outflow tract obstruction.

  2008cited by this paper
• Tissue Doppler imaging to predict clinical course of patients with hypertrophic cardiomyopathy.

  2008cited by this paper
• American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography.

  2008cited by this paper
• Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

  2008cited by this paper
• Systolic myocardial mechanics in hypertrophic cardiomyopathy: novel concepts and implications for clinical status.

  2008cited by this paper
• Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

  2008cited by this paper
• Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging.

  2008cited by this paper
• Evaluation of Left Ventricular Filling Pressures by Doppler Echocardiography in Patients With Hypertrophic Cardiomyopathy: Correlation With Direct Left Atrial Pressure Measurement at Cardiac Catheterization

  2007cited by this paper
• Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: past, present and future

  2007cited by this paper
• Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy

  2007cited by this paper
• Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy

  2007cited by this paper
• Right ventricular involvement in hypertrophic cardiomyopathy.

  2007cited by this paper
• Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy

  2006cited by this paper
• Left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy.

  2006cited by this paper
• Quantitative Assessment of Left Ventricular Size and Function: Side-by-Side Comparison of Real-Time Three-Dimensional Echocardiography and Computed Tomography With Magnetic Resonance Reference

  2006cited by this paper
• Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy).

  2006cited by this paper
• Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy

  2005cited by this paper
• How we perform cardiovascular magnetic resonance flow assessment using phase-contrast velocity mapping.

  2005cited by this paper
• Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy

  2005cited by this paper
• Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy

  2005cited by this paper
• Enlarged left atrial volume in hypertrophic cardiomyopathy: a marker for disease severity.

  2005cited by this paper
• The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

  2004cited by this paper
• Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography

  2004cited by this paper
• Left ventricular hypertrabeculation/noncompaction.

  2004cited by this paper
• Safety of stress testing in patients with hypertrophic cardiomyopathy.

  2004cited by this paper
• Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.

  2003cited by this paper
• Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy.

  2003cited by this paper
• Use of strain imaging in detecting segmental dysfunction in patients with hypertrophic cardiomyopathy.

  2003cited by this paper
• Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy.

  2003cited by this paper
• Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy.

  2002cited by this paper
• Long-term outcome in patients with apical hypertrophic cardiomyopathy.

  2002cited by this paper
• Assessment of Diastolic Function With Doppler Tissue Imaging to Predict Genotype in Preclinical Hypertrophic Cardiomyopathy

  2002cited by this paper
• Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy

  2001cited by this paper
• Detection of left ventricular regional relaxation abnormalities and asynchrony in patients with hypertrophic cardiomyopathy with the use of tissue Doppler imaging.

  2000cited by this paper
• Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy.

  2000cited by this paper
• Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy.

  2000cited by this paper
• Targeting percutaneous transluminal septal ablation for hypertrophic obstructive cardiomyopathy by intraprocedural echocardiographic monitoring.

  2000cited by this paper
• A comparison of MRI and echocardiography in hypertrophic cardiomyopathy.

  1999cited by this paper
• Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy.

  1999cited by this paper
• Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy.

  1998cited by this paper
• Noninvasive doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: a simultaneous Doppler echocardiographic and cardiac catheterization study.

  1996cited by this paper
• Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults.

  1995influential reference
• Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients.

  1995cited by this paper
• Morphological Determinants of Echocardiographic Patterns of Mitral Valve Systolic AnteriorMotion in Obstructive Hypertrophic Cardiomyopathy

  1993cited by this paper
• Left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy: increase in gradient after exercise.

  1992cited by this paper
• Benefits of intraoperative echocardiography in the surgical management of hypertrophic cardiomyopathy.

  1992cited by this paper
• Diversity of Structural Mitral Valve Alterations in Hypertrophic Cardiomyopathy

  1992cited by this paper
• Transesophageal Doppler echocardiography in obstructive hypertrophic cardiomyopathy: clarification of pathophysiology and importance in intraoperative decision making.

  1992cited by this paper

• Echocardiographic Texture Analysis Using Machine Learning for Predicting Myocardial Fibrosis in Hypertrophic Cardiomyopathy.

  2025cites this paper
• CT and MR Imaging of Cardiomyopathies in Clinical Practice–An Approach After an Abnormal Echocardiogram or Electrocardiogram

  2025cites this paper
• The Additive Value of Cardiac MRI in Cases of Cardiomyopathy

  2024influential citation
• Evaluation of potential links between phenotypic features and genetic variants in left ventricular outflow tract obstruction in hypertrophic cardiomyopathy using cardiovascular magnetic resonance imaging

  2024cites this paper
• Importance of T1-Mapping Sequence in Patients with Hypertrophic Cardiomyopathy without Foci of Non-Ischemic Myocardial Injury in Late Gadolinium Enhancement Sequence

  2024cites this paper
• The role of echocardiography in management of patients with hypertrophic cardiomyopathy (review)

  2023cites this paper
• Enhancing the Diagnosis of Hypertrophic Cardiomyopathy Diagnosis: A Case of Integrating Cardiac Magnetic Resonance Imaging

  2023cites this paper
• Current use of cardiac MRI in animals.

  2023cites this paper
• Evaluation of Left Ventricular Mass in Different Cardiac Geometry Using Three-Dimensional Contrast-Enhanced Echocardiography.

  2023cites this paper
• Detecting Regional Fibrosis in Hypertrophic Cardiomyopathy: The Utility of Myocardial Strain Based on Cardiac Magnetic Resonance.

  2022cites this paper
• Anatomical-MRI Correlations in Adults and Children with Hypertrophic Cardiomyopathy

  2022cites this paper
• Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic Cardiomyopathy: An Update from the American Society of Echocardiography, in Collaboration with the American Society of Nuclear Cardiology, the Society for Cardiovascular Magnetic Resonance, and the Society of Card

  2022cites this paper
• Cardiovascular Imaging in Pregnancy: Valvulopathy, Hypertrophic Cardiomyopathy, and Aortopathy

  2022cites this paper
• Screening for hypertrophic cardiomyopathy

  2021cites this paper
• Efficacy of Novel Noncontrast Cardiac Magnetic Resonance Methods in Indicating Fibrosis in Hypertrophic Cardiomyopathy

  2021cites this paper
• Familial Hypertrophic Cardiomyopathy: Late Potentials and Other Prognostic Markers

  2020influential citation
• Segmental longitudinal strain as the most accurate predictor of the patchy pattern late gadolinium enhancement in hypertrophic cardiomyopathy.

  2020cites this paper
• Whole-genome DNA sequencing: The key to detecting a sarcomeric mutation in a 'false genotype-negative' family with hypertrophic cardiomyopathy.

  2020cites this paper
• Prevalence of Unexplained Left Ventricular Hypertrophy by Cardiac Magnetic Resonance Imaging in MESA

  2019cites this paper
• Cardiomyopathies

  2019cites this paper
• T cardiac magnetic resonance intravoxel incoherent motion in evaluating microvascular dysfunction of hypertrophic cardiomyopathy patients

  2019cites this paper
• Is there a role for cardiac positron emission tomography in hypertrophic cardiomyopathy?

  2019cites this paper
• Invited Commentary: A Case of Multiple Ventricular Gradients.

  2018cites this paper